A non-linear association between low-density lipoprotein cholesterol and the risk of diabetic kidney disease in patients with type 2 diabetes in China

被引:1
作者
Xiang, Xi [1 ]
Chen, Guangming [2 ]
Ma, Yongjun [1 ]
Wang, Huabin [1 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Clin Lab, Sch Med, Jinhua 321000, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Gen Practice, Sch Med, Jinhua, Peoples R China
关键词
Low-density lipoprotein cholesterol; Non-linear association; Diabetes kidney disease; Type; 2; diabetes; Restricted cubic spline curves; PLASMA TRIGLYCERIDES; STATINS; PROGRESSION;
D O I
10.1016/j.pmedr.2024.102840
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To explore the intrinsic relationship between low-density lipoprotein cholesterol (LDL-C) and diabetic kidney disease (DKD) in patients with type 2 diabetes (T2D) in China. Methods: This cross-sectional study included 1,313 patients with type 2 diabetes treated at the Affiliated Jinhua Hospital of Zhejiang University School of Medicine, located in Jinhua, China. The data were combined from two periods, 2017 and 2020-2021. Participants were categorized into groups with and without DKD. The relationship between LDL-C levels and DKD was evaluated employing logistics regression analysis and restricted cubic spline (RCS) curves. Results: Generally, there was no statistical difference in LDL-C levels between DKD and non-DKD groups, however, a significantly non-linear relationship (P non-linear = 0.011) was observed between LDL-C levels and DKD prevalence after adjusting for confounding factors according to the RCS analysis. Two optimal cut-points of 2.97 and 3.61 mmol/L were selected out using random forest algorithm. With the middle LDL-C concentration (2.97-3.61 mmol/L) as the reference, the odds ratios for low (<2.97 mmol/L) and high (>3.61 mmol/L) concentrations were 1.45 (1.08-1.96) and 1.47 (1.01-2.15) respectively, after adjusting for confounding factors in the multivariate analyses. Notably, this association was more pronounced among female participants in the subgroup analyses. Conclusion: A non-linear association was observed between LDL-C levels and the risk of DKD in patients with T2D in China. LDL-C levels below 2.97 mmol/L may elevate the risk of DKD, particularly in female patients with T2D.
引用
收藏
页数:7
相关论文
共 35 条
[1]   Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction [J].
Ahn, Hee-Sung ;
Kim, Jong Ho ;
Jeong, Hwangkyo ;
Yu, Jiyoung ;
Yeom, Jeonghun ;
Song, Sang Heon ;
Kim, Sang Soo ;
Kim, In Joo ;
Kim, Kyunggon .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) :1-19
[2]   Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway [J].
Bussolati, B ;
Deregibus, MC ;
Fonsato, V ;
Doublier, S ;
Spatola, T ;
Procida, S ;
Di Carlo, F ;
Camussi, G .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :1936-1947
[3]   Significant association of urinary alpha-1-microglobulin compared to urinary neutrophil gelatinase-associated lipocalin with renal insufficiency in patients with type 2 diabetes [J].
Chen, Guangming ;
Shan, Xiaoyun ;
Wang, Huabin .
NEPHROLOGY, 2021, 26 (05) :400-407
[4]   Non-linear association of fasting C-peptide and uric acid levels with renal dysfunction based on restricted cubic spline in patients with type 2 diabetes: A real-world study [J].
Chen, Lu ;
Hu, Yifei ;
Ma, Yongjun ;
Wang, Huabin .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[5]  
Chinese Diabetes Society, 2023, Zhonghua Nei Ke Za Zhi, V62, P1394, DOI 10.3760/cma.j.cn112138-20231017-00223
[6]   Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease [J].
Coca, Steven G. ;
Nadkarni, Girish N. ;
Huang, Yuan ;
Moledina, Dennis G. ;
Rao, Veena ;
Zhang, Jane ;
Ferket, Bart ;
Crowley, Susan T. ;
Fried, Linda F. ;
Parikh, Chirag R. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (09) :2786-2793
[7]   The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD [J].
de Sa, Joao Roberto ;
Rangel, Erika Bevilaqua ;
Canani, Luis Henrique ;
Bauer, Andrea Carla ;
Escott, Gustavo Monteiro ;
Zelmanovitz, Themis ;
Bertoluci, Marcello Casaccia ;
Silveiro, Sandra Pinho .
DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)
[8]   Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease [J].
de Vries, Aiko P. J. ;
Ruggenenti, Piero ;
Ruan, Xiong Z. ;
Praga, Manuel ;
Cruzado, Josep M. ;
Bajema, Ingeborg M. ;
D'Agati, Vivette D. ;
Lamb, Hildo J. ;
Barlovic, Drazenka Pongrac ;
Hojs, Radovan ;
Abbate, Manuela ;
Rodriquez, Rosa ;
Mogensen, Carl Erik ;
Porrini, Esteban .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (05) :417-426
[9]   Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia [J].
Durcan, Emre ;
Ozkan, Serbay ;
Saygi, Halil Ibrahim ;
Dincer, Mevlut Tamer ;
Korkmaz, Ozge Polat ;
Sahin, Serdar ;
Karaca, Cebrail ;
Sulu, Cem ;
Bakir, Alev ;
Ozkaya, Hande Mefkure ;
Trabulus, Sinan ;
Guzel, Elif ;
Seyahi, Nurhan ;
Gonen, Mustafa Sait .
JOURNAL OF DIABETES, 2022, 14 (04) :236-246
[10]   New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism [J].
Eid, Stephanie ;
Sas, Kelli M. ;
Abcouwer, Steven F. ;
Feldman, Eva L. ;
Gardner, Thomas W. ;
Pennathur, Subramaniam ;
Fort, Patrice E. .
DIABETOLOGIA, 2019, 62 (09) :1539-1549